Anti-TNFα antibody versus non-anti-TNFα molecular agents for ulcerative colitis patients who failed initial anti-TNFα therapy.
Kanayama K, Kato J, Shiratori W, Nagashima A, Ohta Y, Taida T, Saito K, Goto C, Takahashi S, Horio R, Kurosugi A, Ishikawa T, Kaneko T, Akizue N, Okimoto K, Matsumura T, Kato N.
Kanayama K, et al. Among authors: kato j, kato n.
J Gastroenterol Hepatol. 2022 Jun;37(6):1083-1089. doi: 10.1111/jgh.15826. Epub 2022 Mar 17.
J Gastroenterol Hepatol. 2022.
PMID: 35263810